…antiviral drug remdesivir (RDV) and ZMapp, a mixture of three antibodies that bind to proteins on ebolaviruses. ZMapp was administered to infected individuals during the 2014–16 outbreak, though its effectiveness was unclear. In trials during the 2018–20 Ebola outbreak, both REGN-EB3 and mAb114 were found to be more effective at…
Read More